Planet 13 Holdings (PLNH) Capital Expenditures (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Capital Expenditures came in at $665171.0 in Q1 2026, down 75.28% year-on-year from $2.7 million in Q1 2025, and down 11.99% on a QoQ basis from $755761.0 in Q4 2025.
Planet 13 Holdings (PLNH) Capital Expenditures (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Capital Expenditures data on file, last reported at $665171.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 75.28% year-over-year to $665171.0 in Q1 2026; TTM through Mar 2026 was $4.5 million, a 61.44% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 45.44% from the prior year.
- Capital Expenditures for Q1 2026 stood at $665171.0, down from $755761.0 in the prior quarter.
- Over the last five years, Capital Expenditures for PLNH reached as high as $7.7 million in Q2 2022 and fell as low as $417328.0 in Q2 2023.
- Historically, Capital Expenditures has averaged $2.6 million across 5 years, with a median of $2.5 million in 2024.
- Across the five-year window, Capital Expenditures slumped 94.59% in 2023 and soared 875.57% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $2.0 million in 2022, then advanced by 15.64% to $2.4 million in 2023, then increased by 9.04% to $2.6 million in 2024, then tumbled by 70.51% to $755761.0 in 2025, then slipped by 11.99% to $665171.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $665171.0 in Q1 2026, $755761.0 in Q4 2025, and $848734.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 168.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 110.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.95 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 99.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 39.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 51.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | 665,171.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 665,171.00 |
| Mar 31, 2026 | 665,171.00 |
| Dec 31, 2025 | 755,761.00 |
| Dec 31, 2025 | 755,761.00 |
| Sep 30, 2025 | 848,734.00 |
| Sep 30, 2025 | 848,734.00 |
| Jun 30, 2025 | 2.28 Mn |
| Jun 30, 2025 | 2.28 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Dec 31, 2024 | 2.56 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Sep 30, 2024 | 2.46 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Mar 31, 2024 | 2.95 Mn |
| Dec 31, 2023 | 2.35 Mn |
| Dec 31, 2023 | 2.35 Mn |